EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

Stanford University

Status: Completed

Conditions: Eye-tracking

Treatments: Device: Desktop Eye-Tracker; Device: EYE-SYNC eye-tracking device; Other: SCAT-3

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT02844543

34662

Details and patient eligibility

About

This study will assess the effects of exercise and non-concussive bodily contact on eye-tracking scores collected by the EYE-SYNC eye-tracking device.

Full description

The investigators propose to prospectively study a cohort of 18-25-year-old athletes. Athletes will be tested with the EYE-SYNC eye-tracking device prior to the start of an athletic practice or competition (pre-test) and then after the conclusion of the practice/competition (post-test). The investigators hope to understand if eye-tracking scores are effected by exercise and non-concussive bodily contact commonly incurred during athletic play.

Enrollment: 155 patients

Sex: All

Ages: 18 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Athletes between the age of 18- 25-years-old.
• 20/30 or better eyesight (corrected vision allowed).
• English fluency.

Exclusion criteria

Note: Under Cohort 1, Athletes that have conditions listed below will not be excluded from the study. They will be enrolled and their subject data will be analyzed separately from subjects who do not endorse any significant medical hx under neurological, eye-sight, or psychiatric categories.

• Clinical diagnosis of a neurological condition including the following: Stroke, Multiple Sclerosis, Epilepsy, Brain Tumor/Cancer, Nystagmus and/or other major neurological condition.

• Clinical diagnosis of any of the following eye-sight abnormalities: Uncorrected Amblyopia, Uncorrected Myopia, Uncorrected Presbyopia, Uncorrected Farsightedness, or Uncorrected Astigmatism.

• Psychiatric history with any of the following:

  1. Clinical diagnosis of a psychotic disorder, bipolar disorder - lifetime

  2. Clinical diagnosis of ADHD or ADD - Lifetime

  3. Clinical diagnosis of major depressive disorder - within last year

  4. Clinical diagnosis of substance abuse disorder - within last year

  5. Clinical diagnosis of major anxiety disorder - within last year

     MEDICATION

  6. Requires use of a psychotropic medication.

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

155 participants in 1 patient group

Athletes

Experimental group

Description:

Participants will be evaluated using the EYE-SYNC eye-tracking device, Desktop Eye-Tracker, and Sport Concussion Assessment Tool (SCAT-3) tool.

Treatment:

Other: SCAT-3

Device: EYE-SYNC eye-tracking device

Device: Desktop Eye-Tracker